Article ID Journal Published Year Pages File Type
5411054 Journal of Molecular Liquids 2015 7 Pages PDF
Abstract
Our results suggest that the new synthesized Pd(II) complex can bind to the blood carrier protein of HSA and change the tertiary and secondary structures of protein, which can be considered as side effects of these new synthesized drugs.
Keywords
Related Topics
Physical Sciences and Engineering Chemistry Physical and Theoretical Chemistry
Preview
Probing the binding site of a new synthesized anti-cancer compound to HSA via competitive ligand binding method
Authors
, ,